inositol has been researched along with Recrudescence in 5 studies
Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although peri-conceptional folic acid (FA) supplementation can prevent a proportion of neural tube defects (NTD), there is increasing evidence that many NTD are FA non-responsive." | 9.22 | Inositol for the prevention of neural tube defects: a pilot randomised controlled trial. ( Burren, K; Chitty, LS; Copp, AJ; Gay, V; Greene, ND; Leung, KY; Mills, K, 2016) |
| "Although peri-conceptional folic acid (FA) supplementation can prevent a proportion of neural tube defects (NTD), there is increasing evidence that many NTD are FA non-responsive." | 5.22 | Inositol for the prevention of neural tube defects: a pilot randomised controlled trial. ( Burren, K; Chitty, LS; Copp, AJ; Gay, V; Greene, ND; Leung, KY; Mills, K, 2016) |
| "In the multiple sclerosis white matter lesions, N-acetylaspartate (NAA), choline (Cho), inositol (Ins), and creatine (Cr) peaks did not vary significantly over the entire period of the study in the untreated group." | 3.70 | 1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study. ( Alberti, A; Gallai, V; Gobbi, G; Orlacchio, A; Pelliccioli, GP; Presciutti, O; Sarchielli, P; Tarducci, R, 1998) |
| "The neural underpinnings of major depressive disorder (MDD) are unknown but there is evidence for structural alteration in the hippocampus that may become more pronounced over the course of illness." | 1.35 | Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: a proton magnetic resonance spectroscopy study. ( Hall, GB; MacQueen, GM; Milne, A; Soreni, N; Yucel, K, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Greene, ND | 1 |
| Leung, KY | 1 |
| Gay, V | 1 |
| Burren, K | 1 |
| Mills, K | 1 |
| Chitty, LS | 1 |
| Copp, AJ | 1 |
| Milne, A | 1 |
| MacQueen, GM | 1 |
| Yucel, K | 1 |
| Soreni, N | 1 |
| Hall, GB | 1 |
| Parikh, SV | 1 |
| LeBlanc, SR | 1 |
| Ovanessian, MM | 1 |
| Levine, J | 1 |
| Barak, Y | 1 |
| Kofman, O | 1 |
| Belmaker, RH | 1 |
| Sarchielli, P | 1 |
| Presciutti, O | 1 |
| Tarducci, R | 1 |
| Gobbi, G | 1 |
| Alberti, A | 1 |
| Pelliccioli, GP | 1 |
| Orlacchio, A | 1 |
| Gallai, V | 1 |
2 trials available for inositol and Recrudescence
| Article | Year |
|---|---|
Inositol for the prevention of neural tube defects: a pilot randomised controlled trial.
Topics: Adult; Cohort Studies; Dietary Supplements; Double-Blind Method; Feasibility Studies; Female; Folic | 2016 |
Follow-up and relapse analysis of an inositol study of depression.
Topics: Adult; Antidepressive Agents; Bipolar Disorder; Depressive Disorder; Double-Blind Method; Female; Fo | 1995 |
3 other studies available for inositol and Recrudescence
| Article | Year |
|---|---|
Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder: a proton magnetic resonance spectroscopy study.
Topics: Adult; Analysis of Variance; Aspartic Acid; Choline; Depressive Disorder, Major; Female; Glutamic Ac | 2009 |
Advancing bipolar disorder: key lessons from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD).
Topics: Anticonvulsants; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; | 2010 |
1H-MRS in patients with multiple sclerosis undergoing treatment with interferon beta-1a: results of a preliminary study.
Topics: Adult; Brain; Choline; Creatinine; Disability Evaluation; Humans; Inositol; Interferon-beta; Magneti | 1998 |